Purchases and Sales Made in Q4 2024 in Vincerx Pharma, Inc. (VINC)
This table provides information about the institutional ownership of Vincerx Pharma, Inc. (VINC) during Q4 2024. The information is specifically focused on institutions that hold shares of Vincerx Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Ubs Group Ag
|
BUY
|
- |
92.5K+ 38882.77% |
$17.6K - $67.6K
|
92.8K
$59.4K
|
|
|
Feb 14, 2025
Q4 2024
|
Hrt Financial LP
New York, NY |
BUY
|
- |
45.1K+ 306.8% |
$8.57K - $32.9K
|
59.8K
$38.3K
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
340+ 19.43% |
$64.6 - $248
|
2.09K
$1.34K
|
|
|
Feb 14, 2025
Q4 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
26+ 12.32% |
$4.94 - $19
|
237
$152
|
|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-27- -0.0% |
$5.13 - $19.7
|
631K
$404K
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-35- 60.34% |
$6.65 - $25.6
|
23
$14.7
|
|
|
Feb 12, 2025
Q4 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-9.28K- 3.7% |
$1.76K - $6.78K
|
242K
$155K
|
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-9.72K- 46.47% |
$1.85K - $7.09K
|
11.2K
$7.16K
|
|
|
Feb 14, 2025
Q4 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-10.6K- 33.17% |
$2.02K - $7.74K
|
21.4K
$13.7K
|
|
|
Feb 13, 2025
Q4 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-43.9K- 66.52% |
$8.34K - $32K
|
22.1K
$14.1K
|
|
|
Feb 11, 2025
Q4 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-341K- 54.36% |
$64.8K - $249K
|
286K
$183K
|
|
|
Feb 14, 2025
Q4 2024
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-2.14M- 79.03% |
$406K - $1.56M
|
567K
$363K
|